Pulse wave analysis of the radial artery waveform: a proof-of-concept for noninvasive anemia detection

Anemia is a global health concern, particularly in the elderly, and is often underdiagnosed early. Current non-invasive methods like pulse oximetry cannot assess hemoglobin levels. The radial artery blood pressure waveform (BPW), which can be captured via wrist-worn devices, offers a promising but underexplored source of information for this purpose. This study aimed to develop and validate a frequency-domain analysis method, Pulse Frequency-Distribution Analysis (PFDA), using only the wrist BPW for non-invasive anemia detection. In a hospital-based study, 103 older adults (≥65 years) were grouped into Robust (Hb-NA, n = 53) and Anemic (Hb-A, n = 50) based on clinical hemoglobin standards. From the BPW signal, we extracted 40 harmonic-related parameters. The BPW-based PFDA model demonstrated acceptable discrimination, with an overall AUC of 0.72. Gender-specific models performed similarly or better than the overall model, with performance notably enhanced in males (AUC = 0.80). PFDA scores correlated more strongly with hemoglobin levels (|R| > 0.38) than BPW-derived heart rate (|R| < 0.14) and showed relative independence from physiological parameters like blood pressure and age (all R 2 < 0.05). This proof-of-concept study validates that the radial BPW alone contains sufficient physiological information for anemia screening. The proposed PFDA model is an accurate, stable, and computationally efficient tool, indicating considerable potential as a data-efficient solution for integration into wrist-worn wearable devices to facilitate early, non-invasive detection of anemia. • Validates radial artery waveform as a mechanical biomarker for anemia. • PFDA model achieves AUCs of 0.80 (male) and 0.73 (female) for anemia screening. • PFDA-hemoglobin correlation ( R ≥ 0.38) surpasses heart rate benchmark • Offers a rule-based, computationally efficient framework for clinical deployment. • A step toward wearable, non-invasive anemia screening tools.

Authors

Publication Details

Journal
Sensing and Bio-Sensing Research
Published
2025-12-01
DOI
https://doi.org/10.1016/j.sbsr.2025.100934
Primary Topic
Erythropoietin and Anemia Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pulse wave analysis of the radial artery waveform: a proof-of-concept for noninvasive anemia detection

Senyeong Kao, Hsin Hsiu, Ye Chen, Li-Wei Wu et al.
Sensing and Bio-Sensing Research
Erythropoietin and Anemia Treatment
article

Pulse wave analysis of the radial artery waveform: a proof-of-concept for noninvasive anemia detection

Senyeong Kao, Hsin Hsiu, Ye Chen, Li-Wei Wu, Hsin-Wei Lin, Yu-Ting Juang
article en

Abstract

Anemia is a global health concern, particularly in the elderly, and is often underdiagnosed early. Current non-invasive methods like pulse oximetry cannot assess hemoglobin levels. The radial artery blood pressure waveform (BPW), which can be captured via wrist-worn devices, offers a promising but underexplored source of information for this purpose. This study aimed to develop and validate a frequency-domain analysis method, Pulse Frequency-Distribution Analysis (PFDA), using only the wrist BPW for non-invasive anemia detection. In a hospital-based study, 103 older adults (≥65 years) were grouped into Robust (Hb-NA, n = 53) and Anemic (Hb-A, n = 50) based on clinical hemoglobin standards. From the BPW signal, we extracted 40 harmonic-related parameters. The BPW-based PFDA model demonstrated acceptable discrimination, with an overall AUC of 0.72. Gender-specific models performed similarly or better than the overall model, with performance notably enhanced in males (AUC = 0.80). PFDA scores correlated more strongly with hemoglobin levels (|R| > 0.38) than BPW-derived heart rate (|R| < 0.14) and showed relative independence from physiological parameters like blood pressure and age (all R 2 < 0.05). This proof-of-concept study validates that the radial BPW alone contains sufficient physiological information for anemia screening. The proposed PFDA model is an accurate, stable, and computationally efficient tool, indicating considerable potential as a data-efficient solution for integration into wrist-worn wearable devices to facilitate early, non-invasive detection of anemia. • Validates radial artery waveform as a mechanical biomarker for anemia. • PFDA model achieves AUCs of 0.80 (male) and 0.73 (female) for anemia screening. • PFDA-hemoglobin correlation ( R ≥ 0.38) surpasses heart rate benchmark • Offers a rule-based, computationally efficient framework for clinical deployment. • A step toward wearable, non-invasive anemia screening tools.

Sensing and Bio-Sensing Research
Openalex Percentile: Top 45%
Erythropoietin and Anemia Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.